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Abstract
Background: Recurrent aphthous stomatitis (RAS) is a common oral mucosal disorder of unclear etiopathogenesis.
Although recent studies of the oral microbiota by high-throughput sequencing of 16S rRNA genes have suggested
that imbalances in the oral microbiota may contribute to the etiopathogenesis of RAS, no specific bacterial species
associated with RAS have been identified. The present study aimed to characterize the microbiota in the oral
mucosa and saliva of RAS patients in comparison with control subjects at the species level.
Results: The bacterial communities of the oral mucosa and saliva from RAS patients with active lesions (RAS, n = 18
for mucosa and n = 8 for saliva) and control subjects (n = 18 for mucosa and n = 7 for saliva) were analyzed by
pyrosequencing of the 16S rRNA genes. There were no significant differences in the alpha diversity between the
controls and the RAS, but the mucosal microbiota of the RAS patients showed increased inter-subject variability. A
comparison of the relative abundance of each taxon revealed decreases in the members of healthy core microbiota
but increases of rare species in the mucosal and salivary microbiota of RAS patients. Particularly, decreased
Streptococcus salivarius and increased Acinetobacter johnsonii in the mucosa were associated with RAS risk. A
dysbiosis index, which was developed using the relative abundance of A. johnsonii and S. salivarius and the
regression coefficients, correctly predicted 83 % of the total cases for the absence or presence of RAS. Interestingly,
A. johnsonii substantially inhibited the proliferation of gingival epithelial cells and showed greater cytotoxicity
against the gingival epithelial cells than S. salivarius.
Conclusion: RAS is associated with dysbiosis of the mucosal and salivary microbiota, and two species associated with
RAS have been identified. This knowledge may provide a diagnostic tool and new targets for therapeutics for RAS.
Keywords: Recurrent aphthous stomatitis, Oral microbiota, Pyrosequencing
Background
Recurrent aphthous stomatitis (RAS) is one of the most
common oral mucosal disorders affecting at least 10 to
20 % of the general population [1]. RAS is characterized by
the recurrent occurrence of well-circumscribed, single or
multiple ulcers that are extremely painful and heal more
slowly than traumatic ulcers of similar size [2]. Diverse fac-
tors, including genetic predisposition, immunologic distur-
bances, viral and bacterial infections, food allergies, vitamin
and microelement deficiencies, systemic diseases, hormonal
imbalance, mechanical injuries, and stress, have been
suggested to trigger or to be associated with RAS [3]. How-
ever, the etiopathogenesis of RAS remains unclear. Conse-
quently, no curative treatment is available and patient care
primarily consists of symptomatic treatment [1].
Among the bacterial infections, the role of a Strepto-
coccus strain (first identified as S. sanguinis but now re-
classified as S. oralis) has been extensively studied since
its isolation from a RAS lesion. Cross-reaction of anti-
Streptococcal antibodies with autoantigens in the oral
mucosa was proposed as an etiopathogenic mechanism
of RAS, but no evidence to support this hypothesis has
been found [4]. Later, lack of association between S. ora-
lis and RAS was reported based on the less frequent
detection of S. oralis in RAS than in healthy control
samples [5]. Cross-reactive recognition of the mycobac-
terial and human heat shock protein 65-60 antigen by T
cells of RAS patients has been reported, suggesting the
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role of Mycobacterium tuberculosis and autoreactive T
cells in RAS [6]. Accumulated evidence supports the as-
sociation between RAS and Helicobacter pylori infection,
but the presence of H. pylori at the RAS lesions is con-
troversial [7, 8]. In an attempt to discover the micro-
organisms present in RAS lesions, Marchini et al. [9]
studied the mucosal microbiota in RAS patients using a
culture-independent method. Due to limitations in the
methods available at that time, only 57 and 38 phylo-
types were defined from 10 RAS and 10 healthy subjects,
respectively. Recently, the salivary microbiota in patients
with inflammatory bowel disease, where RAS is one of
the extraintestinal manifestations of inflammatory bowel
disease [10], and the oral mucosal microbiota in RAS pa-
tients have been studied by high-throughput sequencing
of the 16S rRNA genes [11, 12]. In addition, Terminal-
Restriction Fragment Length Polymorphism analysis of
bacterial 16S rRNA genes, the human oral microbe iden-
tification microarrays, and matrix-assisted laser desorp-
tion/ionization time-of-flight analysis have been applied
to study the oral microbiota of RAS patients [13, 14]. Al-
though all previous studies suggested that imbalances in
the oral microbiota may be involved in the etiopathogen-
esis of RAS, no specific bacterial species associated with
RAS have been identified. We previously characterized
the murine oral microbiota to the species level by pyrose-
quencing [15]. Therefore, this study aimed to characterize
the microbiota of the oral mucosa and saliva of RAS pa-
tients compared with control subjects at the species level.
Pyrosequencing analysis successfully characterized the
oral microbiota of RAS patients and identified two species
associated with RAS risk.
Results
Subjects
The demographic data of RAS patients and control sub-
jects included in the current study are summarized in
Table 1. Nine males and nine females with the active le-
sions of minor RAS were included and the age distribu-
tion of the patients was 19 to 81 years. The mucosal
sampling sites of RAS lesions included the tip of the
tongue (n = 4), the buccal mucosa (n = 4), and the labial
mucosa (n = 10). Twelve patients had a single ulcer and
six patients had multiple ulcers on the tip of the tongue,
labial mucosa, and soft palate. The control group included
eight males and 10 females with an age distribution of 21
to 71 years. The mucosal sampling sites included the buc-
cal mucosa (n = 11) and the labial mucosa (n = 7).
The alpha and beta diversities of the oral microbiota
From the 51 communities, total 484,501 filtered reads
(average 9500 reads per sample) with an average length
of 479 bp were obtained, which resulted in greater than
99 % Good’s coverage for each sample. We first com-
pared the alpha diversity between the control and RAS
group. The species richness of the RAS microbiota esti-
mated by Chao 1 was not significantly different from
that of controls either in the mucosa (314 ± 19 vs. 292 ±
22) or in the saliva (377 ± 14 vs. 447 ± 33). The diversities
of RAS microbiota determined by the Shannon index were
also comparable to those of controls both in the mucosa
(3.57 ± 0.11 vs. 3.56 ± 0.06) and in the saliva (4.02 ± 0.09
vs. 4.21 ± 0.1) (Fig. 1a).
UniFrac-based principal coordinate analysis (PCoA) to
determine variation among the samples revealed that the
microbiota profile was differentiated better by the ana-
tomical sites, i.e., mucosal surfaces vs. saliva, than by dis-
ease. The different locations in the mucosa, i.e., tongue
tip, labial, or buccal, did not show distinct clustering
(Fig. 1b). Although PCoA clustering did not reveal clear
separation between the control and RAS communities,
the intergroup UniFrac distance (0.061 ± 0.001) was higher
than the intragroup distance of controls (0.057 ± 0.001),
suggesting a significant difference in the bacterial profile
between control and RAS samples. In addition, a higher
intragroup UniFrac distance in the RAS (0.067 ± 0.001)
compared to the control group suggested the increased
inter-subject variability for RAS lesions (Fig. 1c). In the
salivary communities that reflect not only the diseased
sites but also the healthy sites of patients, no significant
differences were observed in intra- or intergroup UniFrac
distances.
Differences in oral microbiota composition between the
control and RAS group
Next, the relative abundance of each taxon between the
control and RAS group was compared. Although a total
of 26 different phyla were identified from the mucosa
samples, Firmicutes, Proteobacteria, Actinobacteria, Bac-
teroidetes, and Fusobacteria encompassed the majority
of the sequences (>99 % in Controls and >97 % in RAS).
The relative abundance of the major phyla observed in
the control subjects was not significantly different from
that of the RAS patients (Fig. 1d). However, the relative
Table 1 The demographic data of the control subjects and RAS
patients
Control subjects (n = 18) RAS patients (n = 18)
Gender 8 males, 10 females 9 males, 9 females
Age 43.6 ± 3.7 43.8 ± 3.9
Ulcer
numbers
- Single: 12 (66.7 %)
Multiple: 6 (33.3 %)
Sampling sites Lip labial mucosa: 7 (38.9 %),
Buccal mucosa: 11 (61.1 %)
Lip labial mucosa: 10 (55.6 %),
Buccal mucosa: 4 (22.2 %)




0.48 ± 0.09 ml/minute 0.67 ± 0.08 ml/minute
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Fig. 1 (See legend on next page.)
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abundance of Streptophyta, a minor phylum, was signifi-
cantly increased in the RAS group (P = 0.03). At the genus
level, Streptococcus constituted almost half of the total
mucosal microbiota in the control group and the other
major genera included Haemophilus, Rothia, Neisseria,
Actinomyces, and Veillonella. Compared to controls, the
RAS mucosal communities contained significantly re-
duced abundance of Veillonella (Fig. 1d). Fourteen other
genera also showed differences in the relative abundance
(Table 2). At the species level, the abundance of several
Streptococcus, including S. salivarius, V. dispar, R. dento-
cariosa, A. odontolyticus, and Prevotella histicola was de-
creased in the RAS mucosa. Instead, the abundance of
Acinetobacter oryzae, A. johnsonii, Capnocytophaga sputi-
gena, N. oralis, Myxococcus xanthus, Ruminococcus gna-
vus, and Treponema denticola was increased (Table 2).
The salivary microbiota of RAS tended to contain de-
creased Firmicutes and increased Proteobacteria among
the major phyla, but the differences were not significant.
At the phylum level, only SR1 showed a significant differ-
ence (0.01 ± 0.004 vs 0.6 ± 0.5, P = 0.02). Among the top
15 genera shown in Fig. 1d, the RAS salivary microbiota
was populated by a significantly increased Porphyromonas,
and the relative abundance of three other genera was also
increased (Table 3). At the species level, the abundance of
S. salivarius was decreased in the RAS samples. Instead,
the abundance of N. flava, N. sicca, C. gingivalis, C. sputi-
gena, Aggregatibacter segnis, Abiotrophia defectiva, and
unclassifieded Porphyromonas species (FM995684_s and
Porphyromonas_uc) was increased (Table 3).
Identification of bacterial species associated with RAS
We explored if such changes in the abundance of bacterial
species is associated with RAS risk. A logistic regression
analysis of the top 100 species in the mucosal microbiota
using a forward method revealed that the abundance of S.
salivarius was associated with a reduced RAS risk (OR
0.734 per 1 % increase, CI 95 % 0.565-0.954, P = 0.02), and
the abundance of A. johnsonii was associated with an
increased RAS risk (OR 211 per 1 % increase, CI 95 %
1618-2.7E4, P = 0.03). None of the species in the salivary
microbiota showed significant association with RAS. A
dysbiosis index was defined as 5.35 × [A. johnsonii] - 0.309 ×
[S. salivarius] using the relative abundance of A. johnsonii
and S. salivarius in the mucosa where 5.35 and -0.309 are
the regression coefficients. The dysbiosis index was signifi-
cantly associated with RAS risk (OR 2.76. CI 95 % 1.26-
6.05, P = 0.01) and correctly predicted 83 % of the total
cases for the absence or presence of RAS (94 % of control
and 72 % of RAS, Fig. 2).
To understand the potential role of bacteria in the etio-
pathogenesis of RAS, the effects of two RAS-associated
species on the viability and proliferation of oral epithelial
cells were examined. P. gingivalis, a periodontal pathogen
that has been reported to inhibit wound healing in an in
vitro scratch assay [16], was used as a control. A. johnsonii
showed greater cytotoxicity against HOK-16B cells than S.
salivarius that showed low levels of cytotoxicity only at
MOI 1000 (Fig. 3a). Interestingly, A. johnsonii substan-
tially inhibited the proliferation of HOK-16B cells in a
dose dependant manner (Fig. 3b).
Discussion
In this study, we showed that imbalances in the mucosal
and salivary microbiota are associated with RAS. Among
the top 15 genera observed in the mucosa of control sub-
jects, 13 except for Escherichia and Lautropia were com-
mon to the major genera characterized in normal adults
enrolled in the HMP. Similarly, 14 genera except for Lau-
tropia out of the top 15 genera observed in the saliva were
common to the HMP [17], defining them as the healthy
‘core microbiota’ of oral microbial communities. Although
most of the genus members of the normal flora were
shared between Koreans and the HMP subjects, the order
of the genus composition and the relative abundance of the
major phyla were different (Additional file 1: Figure S1).
Among the 15 species/phylotypes significantly de-
creased in the RAS mucosa compared to the controls,
nine species including S. salivarius, S. parasanguinis, S.
peroris, S. vestibularis, S. lactarius,V. dispar, Rothia den-
tocariosa, Campylobacter concisus, Actinomyces odonto-
lyticus, and P. histicola belonged to those defined as the
normal flora of the oral mucosa [1, 17], and the six un-
classified phylotypes also belonged to Streptococcus and
Prevotella. In contrast, the seven species that were sig-
nificantly increased in the RAS mucosa did not belong
to the normal oral mucosal flora. A. oryzae and N. oralis
have recently been isolated from wild rice and healthy
gingival plaque, respectively [18, 19]. Myxococcus xan-
thus is a ubiquitous soil bacterium [20]. A. johnsonii is
known to be a member of the skin flora [21]. A. johnso-
nii, the species associated with an increased RAS risk,
has been isolated from clinical samples in association
with bacteremia [22]. R. gnavus is a member of the gut
(See figure on previous page.)
Fig. 1 Comparison of mucosal and salivary microbiota between control and RAS. a The species richness estimated by Chao1 and Shannon
diversity index are expressed using box and whisker plots. b PCoA plot generated using weighted Unifrac metric. The two components explained
52 % of variance. (unfilled symbols: control samples, filled symbols: RAS samples). c The intra- and intergroup Unifrac distances of mucosal
communities were obtained using weighted metric. d Double pie charts present the mean relative abundance of dominant phyla (top 5) and
genera (top 15). * denotes significant difference by Mann-Whitney U test (P < 0.01)
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flora [23]. Interestingly, an increase in R. gnavus in the
gut flora is associated with Crohn’s disease [24]. In the
salivary microbiota of RAS patients, the decrease in S.
salivarius and the increase in Capnocytophaga sputigena
were common to the changes observed in the mucosal
microbiota. Capnocytophaga is normally found in the
oral cavity but considered as an opportunistic pathogen
involved in various infections, including endodontic
Table 2 Relative abundancea of taxa differently distributed between the controls and RAU in the mucosal microbiota
Controls (n = 18) RAU (n = 18) P value
Genus Veillonella 1.86 (0.49–10.44) 0.82 (0–3.33) 0.003
Acinetobacter 0 (0–2.54) 1.04 (0–7.69) 0.001
DQ241813_g (Flavobacteriaceae)b 0.05 (0–1.72) 0.14 (0–11.22) 0.04
Lachnoanaerobaculum 0.08 (0.02–0.87) 0.04 (0–0.47) 0.017
Blautia 0 (0–0.24) 0.02 (0–3.73) 0.01
Myxococcus 0 (0–0.14) 0.04 (0–3.73) 0.031
Alloprevotella 0.04 (0–0.22) 0.09 (0–0.49) 0.031
Pseudomonas 0 (0–0.33) 0.02 (0–2.28) 0.027
Atopobium 0.04 (0–0.44) 0 (0–0.42) 0.037
Ruminococcus_g6 0 (0–0.55) 0.02 (0–0.86) 0.031
Faecalibacterium 0 (0–0.09) 0.02 (0–0.58) 0.014
Staphylococcus 0 (0–0.15) 0.02 (0–0.28) 0.009
Streptococcaceae_uc 0.02 (0–0.06) 0 (0–0.04) <0.0001
Flavobacterium 0 (0–0) 0 (0–0.38) 0.047
Clostridium_g6 0 (0–0) 0 (0–0.14) 0.047
Species Streptococcus salivarius 4.84 (0.08–18.08) 0.61 (0–10.20) 0.001
Veillonella dispar 1.63 (0.29–5.30) 0.60 (0–2.16) 0.003
Streptococcus parasanguinis 1.12 (0–11.45) 0.06 (0–0.98) 0.001
Rothia dentocariosa 0.53 (0.01–9.91) 0.10 (0–3.71) 0.034
Acinetobacter oryzae 0 (0–2) 0.75 (0–5.88) 0.01
Actinomyces odontolyticus 0.43 (0–1.73) 0.11 (0–1.45) 0.02
Capnocytophaga sputigena 0.01 (0–0.53) 0.08 (0–3.26) 0.047
Acinetobacter johnsonii 0 (0–0.54) 0.21 (0–1.86) 0.001
Streptococcus_uc 0.14 (0.03–1.35) 0.05 (0–0.16) 0.001
FM997095_s (Streptococcus)b 0.17 (0.01–0.91) 0.03 (0–1.25) 0.005
Neisseria oralis 0 (0–0.16) 0.03 (0–1.83) 0.017
HQ757980_s (Streptococcus)b 0.07 (0–1.15) 0 (0–2.32) 0.017
4P003152_s (Streptococcus)b 0.06 (0–1.27) 0 (0–0.09) 0.006
Campylobacter concisus 0.09 (0–0.52) 0.02 (0–0.14) 0.002
Prevotella histicola 0.01 (0–2.29) 0 (0–0.29) 0.027
Myxococcus xanthus 0 (0–0.14) 0.04 (0–3.73) 0.031
Streptococcus vestibularis 0.02 (0–0.33) 0 (0–1.25) 0.001
Streptococcus lactarius 0.02 (0–0.87) 0 (0–0.10) 0.031
4P002810_s (Prevotella)b 0.05 (0–0.38) 0 (0–0.34) 0.024
Ruminococcus gnavus 0 (0–0.53) 0.02 (0–0.86) 0.034
BABG01000051_s (Faecalibacterium)b 0 (0–0.07) 0.01 (0–0.52) 0.016
Treponema denticola 0 (0–0.10) 0.02 (0–0.14) 0.031
Streptococcaceae_uc_s 0.02 (0–0.06) 0 (0–0.04) <0.0001
FJ976422_s (Alloprevotella)b 0 (0–0.17) 0.01 (0–0.14) 0.047
aRelative abundance expressed as the median and range
bThe lowest taxonomic rank classified to which the unclassified genus or species belongs
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infections, emphysema, and bacteremia [25–27]. Collect-
ively, these results indicate decreases in the members of
healthy core microbiota but increases in rare species in
the mucosal and salivary microbiota of RAS patients.
Particularly, a decrease in S. salivarius and an increase
in A. johnsonii in the mucosa were associated with in-
creased RAS risk.
Hijazi et al. reported changes in the relative abundance
of only five unclassified genera in ulcerated sites of RAS
patients compared with control subjects [12], probably
due to the smaller size of the subjects and the smaller
number of reads per sample compared to the current
study. Because all of the reported genera are unclassified,
it is difficult to appreciate the biological relevance of the
changes in those. However, the increase of Porphyromo-
nadaceae and decrease of Streptococcaceae in RAS re-
ported by Hijazi et al. may agree with the increase of
Porphyromonas in the saliva and decrease of many
streptococcal species in the mucosa observed in the
current study. The decrease in Streptococcus was also
common in two other studies [5, 10]. The decrease of
Veillonella in the RAS oral mucosa coincides with the
study by Seoudi et al. [14]. The abundance of S. oralis
was not different between the control and RAS groups,
confirming the lack of association of S. oralis with RAS
[5]. Either H. pylori or M. tuberculosis, the species pro-
posed as bacterial etiology of RAS [6, 7], was not de-
tected in any subjects of the current study.
Some diseases are associated with changes in microbial
diversity. For example, periodontitis is associated with
the increased diversity of plaque bacteria, while Crohn’s
disease is associated with the reduced diversity of co-
lonic microbiota [28, 29]. RAS was not associated with
changes in the alpha-diversity of the mucosal or salivary
microbiota, which agrees with previous studies [11, 13].
However, increased inter-subject variability of the muco-
sal microbiota was observed in the RAS patients. The in-
creased inter-subject variability was not attributed to the
different sampling sites, because the intragroup distance
of RAS was still significantly higher than that of control
Table 3 Relative abundancea of taxa differently distributed between the controls and RAU in the salivary microbiota
Controls (n = 7) RAU (n = 8) P value
Genus Porphyromonas 0.40 (0.17–2.65) 4.51 (0.88–12.27) 0.006
GU410548_g (SR1)b 0.01 (0–0.02) 0.06 (0–4.72) 0.021
Abiotrophia 0 (0–0) 0.04 (0–0.28) 0.014
Streptococcaceae_uc 0 (0–0.02) 0.03 (0–0.04) 0.029
Species Streptococcus salivarius 2.18 (0.76–10.42) 0.74 (0.03–3.84) 0.021
Neisseria flava 0.06 (0–1.16) 0.53 (0–6.99) 0.04
Capnocytophaga gingivalis 0.21 (0.06–0.62) 0.68 (0.04–3.50) 0.029
Aggregatibacter segnis 0.02 (0–0.19) 0.42 (0–2.65) 0.021
Capnocytophaga sputigena 0.06 (0–0.20) 0.38 (0.06–1.62) 0.004
FM995684_s (Porphyromonas)b 0 (0–0.27) 0.30 (0–3.91) 0.029
4P003196_s (Actinomyces)b 0.03 (0.01–0.42) 0.14 (0.10–2.09) 0.04
Neisseria sicca 0 (0–0.25) 0.17 (0.02–1.37) 0.006
Porphyromonas_uc 0 (0–0.03) 0.06 (0–0.55) 0.04
Abiotrophia defectiva 0 (0–0) 0.03 (0–0.28) 0.04
4P004176_s (SR1)b 0 (0–0.01) 0.03 (0–0.23) 0.021
Streptococcaceae_uc_s 0 (0–0.02) 0.03 (0–0.04) 0.029
aRelative abundance expressed as the median and range

















Fig. 2 Dysbiosis index of RAS. A dysbiosis index was defined as 5.35 ×
[A. johnsonii] - 0.309 × [S. salivarius] using the relative abundance of A.
johnsonii and S. salivarius in the mucosa where 5.35 and -0.309 are the
regression coefficients. The dysbiosis index of 18 control samples and
18 RAS samples are shown. The dotted line indicates cutoff for RAS
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group after removing the tongue tip samples (0.066 ± 0.002
vs. 0.057 ± 0.001, P = 0.0002). A similar high inter-sample
variability has been reported in chemotherapy-related oral
mucositis lesions [30]. The increased inter-subject vari-
ability may underlie the increased number of phylotypes
characterized in the RAS mucosa in a study by Marchini
et al. in which the samples from 10 RAS patients were
pooled [9].
The dysbiosis index developed using the relative abun-
dance of A. johnsonii and S. salivarius correctly predicted
83 % of the total cases for the absence or presence of
RAS. This is a cross-sectional study, and there is no evi-
dence that the bacterial species increased at the RAS le-
sions have a role in the initiation or progression of the
disease. However, the lessons from the study of dental car-
ies and periodontitis suggest that the bacterial species in-
creased at the lesions may include the major pathogenic
bacteria of the disease. Interestingly, A. johnsonii substan-
tially inhibited the proliferation of gingival epithelial cells
and showed increased cytotoxicity against epithelial cells.
It has been reported that the relative abundance of
Streptococcus was negatively associated with the concen-
trations of IL-1β and IL-8 in saliva [11]. Therefore, the im-
balance of A. johnsonii and S. salivarius could contribute
to ulceration, delayed healing, and severe pain caused by
inflammatory cytokines, all of which are associated with
RAS. Further host cell-microbe interactions are currently
being studied.
When the imbalance between the healthy species such
as S. salivarius and the potentially harmful species such as
A. johnsonii is confirmed as the etiology of RAS, either
probiotic application of S. salivarius or antibiotics that se-
lectively kill harmful species but not healthy species may
provide a cure for RAS by restoring the balance.
The current study has several limitations. First, the mu-
cosal specimens of the control subjects were sampled
from the labial and buccal mucosa, while the sampling
sites from the RAS patients also included the tip of the
tongue. Second, the limited number of total cases requires
further study in larger cohorts and also in diverse popula-
tions, considering the differences in the relative abundance
of major phyla comprising healthy microbiota between
Koreans and the HMP subjects. Third, the non-ulcer sites
of RAS patients were not studied. According to the study
by Bankvall et al., the mucosal microbiota at the non-ulcer
sites of RAS patients was different from that of controls,
and the differences were most profound in patients who
had lesions during sampling [13]. We originally designed
the study to compare the mucosal microbiota in the le-
sions of RAS patients also with that in the post-healing
sites. However, only four patients re-visited the clinic for
additional sampling after healing, and those samples were
not included in the current study. Longitudinal studies in
the future will provide valuable evidence for the role of
bacteria in the ediopathogenesis of RAS.
Conclusion
Pyrosequencing analysis successfully characterized the
oral microbiota of RAS patients compared with healthy
controls at the species level. The mucosal microbiota of
RAS lesions are characterized as decreases in the mem-
bers of healthy core microbiota but increases of rare spe-
cies, and a decrease in S. salivarius and an increase in A.
johnsonii are associated with RAS risk. These findings
may provide a diagnostic tool and new targets for the
therapeutic management of RAS.
Methods
Ethics, consent and permissions
This study was performed according to the Declaration
of Helsinki and conformed to the STROBE guidelines.
The protocol was approved by the institutional review
board at the Seoul National University Dental Hospital
(CRI 12018). Written informed consent was obtained
from all subjects.
Study population and sample collection
Twenty patients with minor RAS active lesions who vis-
ited the Oral Medicine Clinic at the Seoul National Uni-
versity Dental Hospital from February 2013 to January
2014 and 20 control subjects without oral mucosal disor-



















































Fig. 3 The effect of RAS-associated bacterial species on the viability and proliferation of human oral epithelial cells. HOK-16B cells were infected
with A. johnsonii, S. salivarius, and P. gingivalis at MOIs of 100, 500, and 1000 for 24. The viability (a) and the number of live HOK-16B cells (b) in six
wells from two independent experiments were determined by trypan blue exclusion and compared with control cells without bacterial infection.
*: P < 0.05, **: P < 0.01, ***: P < 0.001
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or steroid within the last month, and patients with xeros-
tomia (unstimulated whole salivary flow rate <0.1 ml/min)
were excluded. Subjects with other oral mucosal diseases
(Candida count > 1000 colony forming unit/ml, hemato-
logic deficiency related diseases) or systemic diseases that
involve oral ulcers were also excluded. We also compared
the microbiota in the saliva of RAS, which reflects the
microbiota in both the healthy and diseased sites of pa-
tients, with that of control subjects. All subjects were
asked to avoid eating and antiseptic mouthwashes for two
hours before sampling. For the mucosa sampling, a steril-
ized 20 mm × 20 mm polyvinylidene difluorid membrane
(Korea, Seoul, Korea) was placed on the largest ulcerated
area of patients for 30 s. Samples were taken from the la-
bial or buccal mucosa of healthy subjects. A minimum of
2 ml unstimulated whole saliva samples were collected by
a spit method.
DNA extraction, 16S rRNA gene amplification, and
pyrosequencing
Genomic DNA was isolated from the membranes and the
pellets of centrifugated saliva using the PowerSoil DNA
Isolation Kit (MO BIO Laboratories, Carlsbad, CA, USA).
Forty mucosal (n = 20 and n = 20 for Controls and RAS,
respectively) and 20 salivary (n = 10 and n = 10 for Con-
trols and RAS, respectively) samples were subjected to
pyrosequencing analysis. The gDNA was amplified using
primers targeting the V1 to V3 hypervariable regions of
bacterial 16S rRNA gene, and the PCR products were se-
quenced according to the previously described method
[15] using a 454 GS FLX Titanum Sequencing System
(Roche, Branford, CT, USA). Both the 16S rRNA gene
amplification and sequencing were performed at ChunLab
Inc. (Seoul, Korea). Out of the 60 samples analyzed, we
successfully obtained data sets for 39 mucosal (n = 19 and
n = 20 for Controls and RAS, respectively) and 17 salivary
(n = 8 and n = 9 for Controls and RAS, respectively)
microbiota communities. Four samples failed in pyrose-
quencing due to insufficient amplification of the 16S
rRNA genes, although all DNA samples passed the quality
control. Because communities from smokers are excluded
from the final data set, the current study includes only 36
mucosal (n = 18 and n = 18 for Controls and RAS, respect-
ively) and 15 salivary (n = 7 and n = 8 for Controls and
RAS, respectively) microbiota communities. The pyro-
sequencing data, including those from smokers, are avail-
able in the SRP database under the accession number
SRP049562. The results of data analysis including smokers
are also provided as Additional file 1 (Figs. 2 and 3 and
Tables 1, 2 and 3). The entire process from the enrollment
of subjects to the acquisition of final data sets is illustrated





after exclusion of 
smokers
Control RAS
Inc. : no oral mucosal disorders




Exc.: the use of antibiotics or steroid,
xerostomia, other oral mucosal
diseases, systemic diseases
that involve oral ulcers
n=20
Saliva: n=20
Oral mucosa labial: n=8
Oral mucosa buccal: n=12
Saliva: n=20
Oral mucosa labial: n=12
Oral mucosa buccal: n=4
Oral mucosa tongue: n=4
Saliva: n=10
Oral mucosa labial: n=8




Oral mucosa labial: n=7
Oral mucosa buccal: n=12
Saliva: n=7
Oral mucosa labial: n=7
Oral mucosa buccal: n=11
Saliva: n=10
Oral mucosa labial: n=12
Oral mucosa buccal: n=4
Oral mucosa tongue: n=4
Saliva: n=9
Oral mucosa labial: n=12
Oral mucosa buccal: n=4
Oral mucosa tongue: n=4
Saliva: n=8
Oral mucosa labial: n=10
Oral mucosa buccal: n=4
Oral mucosa tongue: n=4
Fig. 4 A flow chart from the enrollment of subjects to the acquisition of final data sets
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Pyrosequencing data analysis
The basic analysis was conducted according to previously
published descriptions [15]. After removing PCR primer
sequences, any reads containing two or more ambiguous
nucleotides or reads shorter than 300 bp were discarded.
Chimera sequences detected by the Bellerophone method
[31] were also removed. The taxonomic classification of
each read was assigned against the EzTaxon database-e
(http://www.ezbiocloud.net/eztaxon) [32]. The species rich-
ness and diversity index were calculated using the Riboso-
mal RNA database project’s pyrosequencing pipeline
(http://pyro.cme.msu.edu). The cutoff value for assigning a
sequence to the same phylotype was ≥ 97 % similarity. Ran-
dom subsampling was conducted to equalize variation in
the read counts among the samples. The overall phylogen-
etic distance between communities was estimated using the
weighted Fast UniFrac [33] and was visualized using PCoA.
In addition, the pyrosequencing data of buccal mucosa and
saliva published by The Human Microbiome Project
(HMP) Consortium [34] were also analyzed to compare
with the control subjects of the current study.
Bacterial and epithelial cell culture
Because isolation of bacteria from the patients was not in-
cluded in the original protocol approved by the institu-
tional review board, type strain was used for additional
functional study. A. johnsonii KCTC 12405 (Korean Col-
lection for Type Culture, Daejeon, Korea) was cultured in
BHI medium at 30 °C and aerobic atmosphere. S. salivar-
ius KCTC 5512 (KCTC) and P. gingivalis ATCC 33277
(American Type Culture Collection, Manassas, VA, USA)
were cultured in ATCC medium 188 and BHI medium
supplemented with 5 μg/ml hemin and 10 μg/ml vitamin
K, respectively, at 37 °C under an anaerobic atmosphere.
Bacteria in log phase growth were harvested and bacterial
concentrations were determined by flow cytometry [35].
Immortalized human oral keratinocyte HOK-16B cells
originated from the retromolar gingival tissue [36] were
maintained in keratinocyte growth-culture medium (Clo-
netics, San Diego, CA, USA) containing supplementary
growth factors. HOK-16B cells plated into 48-well plates
at 4x104 cells/well in triplicate were cultured for 24 h and
then infected with bacteria at the multiplicity of infection
(MOI) 0, 100, 500, and 1000 as previously described [37].
After 24 h of co-culture at 37 °C in a water-saturated at-
mosphere of 95 % air and 5 % CO2, cells were harvested,
including the dead cells in the supernatant. The viability
and total number of live cells in each well were deter-
mined by trypan blue exclusion under a microscope.
Statistics
The data are presented as the mean ± the standard errors
of means, unless described otherwise. The differences in
relative abundance and in UniFrac distances between the
two groups were determined with the Mann-Whitney U-
test and t-test, respectively. The association of bacterial
species with RAS risk was determined with a logistic re-
gression analysis. Differences in the viability and prolifera-
tion between control and infected cells were analyzed by
t-test. All statistics were performed using the SPSS Statis-
tics19 software (SPSS Inc., Chicago, IL, USA). Significance
was set at P < 0.05.
Additional file
Additional file 1: The comparison of the oral mucosa and saliva
microbiota between the control subjects of current study and HMP
subjects at the phylum level. (PDF 428 kb)
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